FDA — authorised 14 October 1999
- Application: BLA020521
- Marketing authorisation holder: ONY
- Indication: Manufacturing (CMC)
- Status: approved
FDA authorised Infasurf on 14 October 1999
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 14 October 1999.
ONY holds the US marketing authorisation.